ArthroCare to Host Conference Call on February 14, 2013
AUSTIN, Texas--(BUSINESS WIRE)--Feb 11, 2013--ArthroCare Corporation (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, plans to release its fourth quarter and year end 2012 results on Thursday, February 14, 2013.
ArthroCare will host a conference call on Thursday, February 14, 2013 at 8:30 a.m. ET to discuss the Company’s operating results. A press release summarizing the results will be made available after market on Wednesday, February 13, 2013. To participate in the live conference call dial 800-763-5654. A live and on-demand webcast of the call will be available on ArthroCare’s Web site at www.arthrocare.com. A telephonic replay of the conference call can be accessed by dialing 800-633-8284 and entering pass code number 21648357. The replay will remain available through February 28, 2013.
ArthroCare develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes. Its devices improve many existing surgical procedures and enable new minimally invasive procedures. Many of ArthroCare’s devices use its internationally patented Coblation ® technology. This technology precisely dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology including its OPUS ® line of fixation products as well as re-usable surgical instruments. ArthroCare is leveraging these technologies in order to offer a comprehensive line of surgical devices to capitalize on a multi-billion dollar market opportunity across several surgical specialties, including its two core product areas consisting of Sports Medicine and Ear, Nose, and Throat as well as other areas such as spine, wound care, urology and gynecology.